SEEGENE, INC. Logo

SEEGENE, INC.

Develops multiplex PCR-based IVD products and automated diagnostic systems.

096530 | KO

Overview

Corporate Details

ISIN(s):
KR7096530001
LEI:
Country:
South Korea
Address:
서울특별시 송파구 오금로 91(방이동) 7층, 서울특별시

Description

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-09-08 00:00
자기주식처분결과보고서
Korean HTML 17.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 3.1 MB
2025-08-08 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean HTML 16.7 KB
2025-08-06 00:00
현금ㆍ현물배당결정 (분기배당)
Korean HTML 8.4 KB
2025-08-06 00:00
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean HTML 5.3 KB
2025-08-06 00:00
주요사항보고서(자기주식처분결정)
Korean HTML 31.3 KB
2025-08-01 00:00
결산실적공시예고
Korean HTML 4.0 KB
2025-06-11 00:00
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean HTML 79.7 KB
2025-06-09 00:00
자기주식처분결과보고서
Korean HTML 17.6 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 2.1 MB
2025-05-09 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean HTML 16.7 KB
2025-05-07 00:00
현금ㆍ현물배당결정 (분기배당)
Korean HTML 8.4 KB
2025-05-07 00:00
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean HTML 5.3 KB
2025-05-07 00:00
주요사항보고서(자기주식처분결정)
Korean HTML 31.4 KB
2025-05-02 00:00
결산실적공시예고
Korean HTML 4.0 KB

Automate Your Workflow. Get a real-time feed of all SEEGENE, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SEEGENE, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SEEGENE, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.